These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38310229)

  • 1. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
    J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huaier Regulates Oxaliplatin Resistance in Colorectal Cancer by Regulating Autophagy and Inhibiting the Wnt/β-catenin Signalling Pathway.
    Feng Q; Huo M; Yan X; Wen L; Zheng J
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):15. PubMed ID: 38287798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
    Fellenberg J; Kunz P; Sähr H; Depeweg D
    PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
    Liu X; Su K; Sun X; Jiang Y; Wang L; Hu C; Zhang C; Lu M; Du X; Xing B
    J Exp Clin Cancer Res; 2021 Apr; 40(1):132. PubMed ID: 33858476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells.
    Wu Z; Zhou S; Liang D; Mu L
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1115-1125. PubMed ID: 37610461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
    J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
    Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
    Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
    Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockage of PD-L1 by FERMT3-mediated Wnt/β-catenin signalling regulates chemoresistance and immune evasion of colorectal cancer cells.
    Tang Y; Nan N; Gui C; Zhou X; Jiang W; Zhou X
    Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):988-997. PubMed ID: 35672907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
    Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
    J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
    Pothuraju R; Rachagani S; Krishn SR; Chaudhary S; Nimmakayala RK; Siddiqui JA; Ganguly K; Lakshmanan I; Cox JL; Mallya K; Kaur S; Batra SK
    Mol Cancer; 2020 Feb; 19(1):37. PubMed ID: 32098629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.